comparemela.com
Home
Live Updates
FDA OKs New Treatment for Erosive Esophagitis : comparemela.com
FDA OKs New Treatment for Erosive Esophagitis
Vonoprazan (Voquezna) is indicated for the healing and maintenance of healing of all grades of erosive esophagitis, as well as relief of associated heartburn in adults.
Related Keywords
United States ,
Colinw Howden ,
,
Drug Administration ,
Phathom Pharmaceuticals ,
University Of Tennessee College Medicine ,
Medscape Medical News ,
Tennessee College ,
Voquezna Triple Pak ,
Voquezna Dual Pak ,
Gastroesophageal Reflux Disease Gerd ,
Gastroesophageal Reflux Disease ,
Herd ,
Acid Reflux Disease ,
Esophagitis ,
Erosive Esophagitis ,
Heartburn ,
Abdominal Pain ,
Abdomen ,
Us Food And Drug Administration ,
Nited States Food And Drug Administration ,
Fda ,
Pain Management ,
Spain ,
Proton Pump Inhibitor ,
Cid Suppressive Therapy ,
Pi Proton Pump Inhibitor ,
Therapy ,
comparemela.com © 2020. All Rights Reserved.